FDA Adverse Event Malfunction Summary report: N

INRATIO

MDR report key: 1813174 · Received August 18, 2010

Report

Report Number
2027969-2010-01236
Event Type
Malfunction
Date Received
August 18, 2010
Date of Event
July 23, 2010
Report Date
August 18, 2010
Manufacturer
ALERE SAN DIEGO, INC
Product Code
GJS
PMA / PMN Number
021923
Removal / Correction Number
NI
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CT, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

DISCREPANT RESULTS (ACCURACY) COMPARISON OF INRATIO TEST WITH LAB RESULTS PROVIDED BY END-USER AT TIME COMPLAINT WAS FILED: INRATIO: 1.6, REFERENCE: 2.3, MEAN: 1.95, CONFIDENCE LIMITS: 1.3-2.7. ANALYSIS OF THE CUSTOMER'S DATA REVEALED THAT INRATIO AND REFERENCE TEST RESULT COMPARISON MEET ACCURACY CRITERIA. THE RESULTS ARE NOT CONSIDERED DISCREPANT WITHIN THE CONTEXT OF THE DOCUMENTED VARIABILITY FOR INR TESTING. PER COMPLAINT DESCRIPTION, PT WAS APPLYING MORE THAN ONE DROP OF BLOOD. DOUBLE DROPPING (ADDING TWO DROPS TO ONE STRIP) IS A KNOWN CAUSE FOR PRE-ANALYTICAL ERRORS IN FINGERSTICK SAMPLE COLLECTION AND COULD PRODUCE INVALID INR VALUES. AS OF 08/18/2010, FIVE DISCREPANT RESULT COMPLAINTS WERE REPORTED FOR LOT #232889 YIELDING A COMPLAINT RATE OF 0.003%. DUE TO THIS LOW OCCURRENCE RATE, BELOW THE ACTION THRESHOLDS MONITORED BY QA FOR CORRECTIVE ACTION (>0.07%), NO FURTHER ACTION IS REQUIRED AT THIS TIME. ONGOING TRENDING SHALL BE PERFORMED TO DETERMINE IF FURTHER ACTION IS WARRANTED. NO CORRECTIVE ACTION IS REQUIRED AT THIS TIME AS NO PRODUCT DEFICIENCY WAS ESTABLISHED.

Description of Event or Problem · 1

CALLER ALLEGED DISCREPANT RESULTS COMPARED WITH THE LAB. RESULTS AS FOLLOW: DATE: (B)(6) 2010, INRATIO: 1.6, LAB: 2.3.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INRATIO PROTHROMBIN TIME TEST GJS ALERE SAN DIEGO, INC 100071 232889

Patients

Seq Age Sex Outcome Treatment
1 NI